STUDY OF PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT AND YOUNG ADULT STUDENTS OF NAVODAYA GROUP OF INSTITUTIONS

KOLAN PALLAVI; HARSHITHA K.

doi:10.22159/ijcpr.2024v16i4.5003

Authors

KOLAN PALLAVI Department of Obstetrics, Dr. Patnam Mahender Reddy Institute of Medical Sciences, Chevella, Ranga Reddy District, Telangana, India
HARSHITHA K. ESIC Hospital, Sanath Nagar, Hyderabad, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i4.5003

Keywords:

Endocrine disorder, Polycystic ovary syndrome, Hirsutism, Rotterdam criteria

Abstract

Objective: Polycystic ovary syndrome (PCOS) is considered to be the most common endocrine disorder in women of reproductive age. The objective of this study was to calculate the prevalence of PCOS in Navodaya group of institutions based on Rotterdam criteria.

Methods: A prospective study of 500 girls of Navodaya group of institutions (school, medical, dental, and nursing, pharmacy, physiotherapy and engineering students) aged 13 to 25 y who underwent clinical examination. Out of which, 68 girls with oligomenorrhea and/or hirsutism were invited for biochemical, hormonal, and ultrasonographic evaluation for diagnosis of PCOS by Rotterdam criteria.

Results: Out of 500 girl students, 68 girls satisfied Rotterdam’s criteria for PCOS. Under the Rotterdam criteria, the estimated prevalence of PCOS in adolescent and young adult students was 13.6%.

Conclusion: Prevalence of PCOS in adolescent and young adult students of Navodaya Group of Institutions was 13.6%. This draws attention to the issue of early diagnosis in adolescent girls.

Downloads

Download data is not yet available.

References

Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32(3):195-201. doi: 10.1016/j.nutres.2012.02.001, PMID 22464806.

Stein IF, leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29(2):181-91. doi: 10.1016/S0002-9378(15)30642-6.

De leo V, La Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev. 2003;24(5):633-67. doi: 10.1210/er.2002-0015, PMID 14570747.

Speroff l, Glass RH, Kase NG. editors. Chapter 6. Anovulation. In: Clinical ynecologic Endocrinology and Infertility, (7th'-Ed.). Baltimore: Williams and Wilkins; 1989. p. 213-31.

Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR. editors. Polycystic ovary syndrome. Polycystic ovary syndrome; 1992. p. 377-84.

Kalro BN, loucks TL, Berga SL. Neuromodulation in polycystic ovary syndrome. Obstet Gynecol Clin North Am. 2001;28(1):35-62. doi: 10.1016/s0889-8545(05)70184-4, PMID 11293003.

Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28(2):341-59. doi: 10.1016/s0889-8529(05)70073-6, PMID 10352922.

Gabrielli L, Aquino EM. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Reprod Biol Endocrinol. 2012 Nov 22;10:96. doi: 10.1186/1477-7827-10-96, PMID 23173761, PMCID PMC3560118.

Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011 Aug;24(4):223-7. doi: 10.1016/j.jpag.2011.03.002, PMID 21600812.

March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399, PMID 19910321.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9. doi: 10.1210/jc.2003-032046, PMID 15181052.

Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(8):2944-51. doi: 10.1210/jc.2006-2336, PMID 17504892.

Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-71. doi: 10.4103/jhrs.JHRS_95_18, PMID 33627974, PMCID PMC7879843.